Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Mechanisms leading to fibroblast accumulation during pulmonary fibrogenesis remain unclear. Although there is in vitro evidence of lung alveolar epithelial-to-mesenchymal transition (EMT), whether EMT occurs within the lung is currently unknown. Biopsies from fibrotic human lungs demonstrate epithelial cells with mesenchymal features, suggesting EMT. To more definitively test the capacity of alveolar epithelial cells for EMT, mice expressing β-galactosidase (β-gal) exclusively in lung epithelial cells were generated, and their fates were followed in an established model of pulmonary fibrosis, overexpression of active TGF-β1. β-gal-positive cells expressing mesenchymal markers accumulated within 3 weeks of in vivo TGF-β1 expression. The increase in vimentin-positive cells within injured lungs was nearly all β-gal-positive, indicating epithelial cells as the main source of mesenchymal expansion in this model. Ex vivo , primary alveolar epithelial cells cultured on provisional matrix components, fibronectin or fibrin, undergo robust EMT via integrin-dependent activation of endogenous latent TGF-β1. In contrast, primary cells cultured on laminin/collagen mixtures do not activate the TGF-β1 pathway and, if exposed to active TGF-β1, undergo apoptosis rather than EMT. These data reveal alveolar epithelial cells as progenitors for fibroblasts in vivo and implicate the provisional extracellular matrix as a key regulator of epithelial transdifferentiation during fibrogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, two important sources of myofibroblasts in SSc are epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndoMT).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“EMT is an important driver of lung fibrosis, in which alveolar epithelial cells become myofibroblasts (95).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“Both processes can be observed in SSc.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“This was demonstrated using alveolar specific lineage tracking, which visualized that alveolar cells started to express αSMA upon overexpression of TGFβ1 (95).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
In the citing paper
“In both processes, respectively epithelial and endothelial cells lose their phenotype and become myofibroblasts.”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [95]
Citations
Cites
1 retracted
RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro
Yao, H.-W., Xie, Q.-M., Chen, J., Deng, Y., & Tang, H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.019 · Cited by 109
RetractedGeneralized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
Kim, C. F. B., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R. T., & Jacks, T. (2005) · Cell · doi:10.1016/j.cell.2005.03.032 · Cited by 2,195
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Self-citationZeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Research works printed but not linked: 2
- 10.1172/jci20530 · doi:10.1172/jci20530 · Paper page
- I. Y. Adamson, D. H. Bowden Lab. Invest. 30, 35–42 (1974).
Cited by
Items 101–200 of 1,001
HIF and the Lung: Role of Hypoxia-inducible Factors in Pulmonary Development and Disease
Shimoda, L. A., & Semenza, G. L. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1393pp · Cited by 277
Lung development and repair: Contribution of the ciliated lineage
Rawlins, E. L., Ostrowski, L. E., Randell, S. H., & Hogan, B. L. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610770104 · Cited by 276
Targeting TGF-β signaling for the treatment of fibrosis
Györfi, A. H., Matei, A.-E., & Distler, J. H. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.016 · Cited by 274
Rout-Pitt, N., Farrow, N., Parsons, D., & Donnelley, M. (2018) · Respiratory Research · doi:10.1186/s12931-018-0834-8 · Cited by 274
The pathogenesis of idiopathic pulmonary fibrosis
Coward, W. R., Saini, G., & Jenkins, G. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379801 · Cited by 272
TGF-β Activation and Lung Fibrosis
Tatler, A. L., & Jenkins, G. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201201-003aw · Cited by 263
Mierke, C. T. (2019) · Reports on Progress in Physics · doi:10.1088/1361-6633/ab1628 · Cited by 262
Oxidative Stress in Pulmonary Fibrosis
Otoupalova, E., Smith, S., Cheng, G., & Thannickal, V. J. (2020) · Comprehensive Physiology · doi:10.1002/cphy.c190017 · Cited by 262
Zhou, B., Liu, Y., Kahn, M., Ann, D. K., Han, A., Wang, H., Nguyen, C., Flodby, P., Zhong, Q., Krishnaveni, M. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276311 · Cited by 261
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Li, L.-C., Li, J., & Gao, J. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218370 · Cited by 261
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis
McKleroy, W., Lee, T.-H., & Atabai, K. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00418.2012 · Cited by 261
Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Salton, F., Volpe, M., & Confalonieri, M. (2019) · Medicina · doi:10.3390/medicina55040083 · Cited by 261
Participation of miR-200 in Pulmonary Fibrosis
Yang, S., Banerjee, S., de Freitas, A., Sanders, Y. Y., Ding, Q., Matalon, S., Thannickal, V. J., Abraham, E., & Liu, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.005 · Cited by 259
Shintani, Y., Maeda, M., Chaika, N., Johnson, K. R., & Wheelock, M. J. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0071oc · Cited by 259
WNT Signaling in Lung Disease: A Failure or a Regeneration Signal?
Königshoff, M., & Eickelberg, O. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0485tr · Cited by 258
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Mehrad, B., Burdick, M. D., Zisman, D. A., Keane, M. P., Belperio, J. A., & Strieter, R. M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.149 · Cited by 255
Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition
Guarino, M., Tosoni, A., & Nebuloni, M. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.02.020 · Cited by 253
Jolly, M. K., Ward, C., Eapen, M. S., Myers, S., Hallgren, O., Levine, H., & Sohal, S. S. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24541 · Cited by 253
Roles of vimentin in health and disease
Ridge, K. M., Eriksson, J. E., Pekny, M., & Goldman, R. D. (2022) · Genes & Development · doi:10.1101/gad.349358.122 · Cited by 251
Matrix Metalloproteinase 3 Is a Mediator of Pulmonary Fibrosis
Yamashita, C. M., Dolgonos, L., Zemans, R. L., Young, S. K., Robertson, J., Briones, N., Suzuki, T., Campbell, M. N., Gauldie, J., Radisky, D. C., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.041 · Cited by 247
Overview of pathogenesis of systemic sclerosis
Abraham, D. J., Krieg, T., Distler, J., & Distler, O. (2006) · Rheumatology · doi:10.1093/rheumatology/ken481 · Cited by 242
Zhou, G., Dada, L. A., Wu, M., Kelly, A., Trejo, H., Zhou, Q., Varga, J., & Sznajder, J. I. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00007.2009 · Cited by 241
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Hardie, W. D., Glasser, S. W., & Hagood, J. S. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.081170 · Cited by 240
Cannito, S., Novo, E., di Bonzo, L. V., Busletta, C., Colombatto, S., & Parola, M. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2737 · Cited by 239
“In these models, EMT seem indeed to represent a major event. d) Less detailed evidence for EMT in human lung biopsies has been provided until now, with co-expression of myofibroblast and AEC markers in AECs reported in biopsies from patients affected by IPF (273) or, again in IPF patients, with signs of EMT consisting…”
InfluentialTanjore, H., Blackwell, T. S., & Lawson, W. E. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00410.2011 · Cited by 236
Future Directions in Idiopathic Pulmonary Fibrosis Research. An NHLBI Workshop Report
Blackwell, T. S., Tager, A. M., Borok, Z., Moore, B. B., Schwartz, D. A., Anstrom, K. J., Bar-Joseph, Z., Bitterman, P., Blackburn, M. R., Bradford, W., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1141ws · Cited by 236
Self-citationDoerner, A. M., & Zuraw, B. L. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-100 · Cited by 234
“In addition, in vivo studies have suggested that EMT may occur in IPF as well as in alveolar and bronchial epithelial cells during bleomycin-induced pulmonary fibrosis [15,44,45].”
BackgroundZheng, G., Lyons, J. G., Tan, T. K., Wang, Y., Hsu, T.-T., Min, D., Succar, L., Rangan, G. K., Hu, M., Henderson, B. R., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080983 · Cited by 230
Tanjore, H., Cheng, D.-S., Degryse, A. L., Zoz, D. F., Abdolrasulnia, R., Lawson, W. E., & Blackwell, T. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.181164 · Cited by 230
Metformin attenuates lung fibrosis development via NOX4 suppression
Sato, N., Takasaka, N., Yoshida, M., Tsubouchi, K., Minagawa, S., Araya, J., Saito, N., Fujita, Y., Kurita, Y., Kobayashi, K., et al. (2016) · Respiratory Research · doi:10.1186/s12931-016-0420-x · Cited by 228
Mechanical Aspects of Lung Fibrosis: A Spotlight on the Myofibroblast
Hinz, B. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201202-017aw · Cited by 228
The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy
Hills, C. E., & Squires, P. E. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.06.002 · Cited by 225
Resolved: EMT Produces Fibroblasts in the Kidney
(2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060616 · Cited by 224
SIRT1 Suppresses the Epithelial-to-Mesenchymal Transition in Cancer Metastasis and Organ Fibrosis
Simic, P., Williams, E. O., Bell, E. L., Gong, J. J., Bonkowski, M., & Guarente, L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.019 · Cited by 221
Origin and functional heterogeneity of fibroblasts
LeBleu, V. S., & Neilson, E. G. (2020) · The FASEB Journal · doi:10.1096/fj.201903188r · Cited by 219
Guo, W., Shan, B., Klingsberg, R. C., Qin, X., & Lasky, J. A. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00128.2009 · Cited by 218
Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis
Redente, E. F., Jacobsen, K. M., Solomon, J. J., Lara, A. R., Faubel, S., Keith, R. C., Henson, P. M., Downey, G. P., & Riches, D. W. H. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2011 · Cited by 215
Xia, H., Diebold, D., Nho, R., Perlman, D., Kleidon, J., Kahm, J., Avdulov, S., Peterson, M., Nerva, J., Bitterman, P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080001 · Cited by 213
Li, M., Krishnaveni, M. S., Li, C., Zhou, B., Xing, Y., Banfalvi, A., Li, A., Lombardi, V., Akbari, O., Borok, Z., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42090 · Cited by 213
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Pain, M., Bermudez, O., Lacoste, P., Royer, P.-J., Botturi, K., Tissot, A., Brouard, S., Eickelberg, O., & Magnan, A. (2014) · European Respiratory Review · doi:10.1183/09059180.00004413 · Cited by 212
Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 211
Integrin-mediated regulation of TGFβ in fibrosis
Henderson, N. C., & Sheppard, D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.005 · Cited by 210
Self-citationAlveolar type 2 progenitor cells for lung injury repair
Olajuyin, A. M., Zhang, X., & Ji, H.-L. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0147-9 · Cited by 207
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
Eferl, R., Hasselblatt, P., Rath, M., Popper, H., Zenz, R., Komnenovic, V., Idarraga, M.-H., Kenner, L., & Wagner, E. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801414105 · Cited by 206
Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis
Ding, N.-H., Li, J., & Sun, L.-Q. (2013) · Current Drug Targets · doi:10.2174/13894501113149990198 · Cited by 206
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Oncotarget · doi:10.18632/oncotarget.21234 · Cited by 204
“Moreover, non-fibroblastic cell lineages [132–134] can differentiate into myofibroblasts through EMT process [135].”
BackgroundCartilage regeneration and ageing: Targeting cellular plasticity in osteoarthritis
Varela-Eirin, M., Loureiro, J., Fonseca, E., Corrochano, S., Caeiro, J. R., Collado, M., & Mayan, M. D. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.006 · Cited by 203
Novel therapeutic approaches for pulmonary fibrosis
Datta, A., Scotton, C. J., & Chambers, R. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01247.x · Cited by 202
Zhong, Q., Zhou, B., Ann, D. K., Minoo, P., Liu, Y., Banfalvi, A., Krishnaveni, M. S., Dubourd, M., Demaio, L., Willis, B. C., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0347oc · Cited by 200
Self-citationEpithelial–mesenchymal transition in the pathophysiology of airway remodelling in asthma
Hackett, T.-L. (2012) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32834ec6eb · Cited by 200
Global Methylation Patterns in Idiopathic Pulmonary Fibrosis
Rabinovich, E. I., Kapetanaki, M. G., Steinfeld, I., Gibson, K. F., Pandit, K. V., Yu, G., Yakhini, Z., & Kaminski, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033770 · Cited by 197
Diminished Prostaglandin E 2 Contributes to the Apoptosis Paradox in Idiopathic Pulmonary Fibrosis
Maher, T. M., Evans, I. C., Bottoms, S. E., Mercer, P. F., Thorley, A. J., Nicholson, A. G., Laurent, G. J., Tetley, T. D., Chambers, R. C., & McAnulty, R. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0674oc · Cited by 196
TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts
Vallée, A., & Lecarpentier, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0362-3 · Cited by 194
Pedroza, M., Le, T. T., Lewis, K., Karmouty‐Quintana, H., To, S., George, A. T., Blackburn, M. R., Tweardy, D. J., & Agarwal, S. K. (2016) · The FASEB Journal · doi:10.1096/fj.15-273953 · Cited by 193
“Current literature suggests that injury to type II AECs leads to the expression of injury markers, including HIF-1a, PAI-1, and HSP-70 (45–47, 58–60), and fibrotic markers, including Col1a1, a-SMA, TWIST, and SNAIL (4, 12, 14, 61).”
BackgroundKagalwalla, A. F., Akhtar, N., Woodruff, S. A., Rea, B. A., Masterson, J. C., Mukkada, V., Parashette, K. R., Du, J., Fillon, S., Protheroe, C. A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.005 · Cited by 193
“Emerging evidence from fields including allergic diseases and asthma suggests that EMT contributes to the genesis of diseaserelated fibroblasts and myofibroblasts and development of tissue fibrosis, representing a significant source of these fibrogenic cells.(9,11,27,28) We demonstrated the presence of vimentin-positi…”
BackgroundInhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Lagares, D., Busnadiego, O., García‐Fernández, R. A., Kapoor, M., Liu, S., Carter, D. E., Abraham, D., Shi‐Wen, X., Carreira, P., Fontaine, B. A., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33482 · Cited by 192
“In fact, the presence of upregulated FAK in bronchial epithelial cells may be indicative that lung epithelial cells contribute to the generation of myofibroblasts through a process of EMT in a FAK-dependent manner (46, 47).”
BackgroundGremlin-mediated Decrease in Bone Morphogenetic Protein Signaling Promotes Pulmonary Fibrosis
Myllärniemi, M., Lindholm, P., Ryynänen, M. J., Kliment, C. R., Salmenkivi, K., Keski-Oja, J., Kinnula, V. L., Oury, T. D., & Koli, K. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-945oc · Cited by 192
Câmara, J., & Jarai, G. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-2 · Cited by 192
Książkiewicz, M., Markiewicz, A., & Żaczek, A. J. (2012) · Pathobiology · doi:10.1159/000337106 · Cited by 190
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 189
“%) and tubular EMT (5%).”
BackgroundInfluentialMitochondrial quality control in pulmonary fibrosis
Larson-Casey, J. L., He, C., & Carter, A. B. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101426 · Cited by 189
Schnittert, J., Bansal, R., Storm, G., & Prakash, J. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.020 · Cited by 188
Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family
Katsuno, Y., & Derynck, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.028 · Cited by 187
Knowns and Unknowns of the Alveolus
Herzog, E. L., Brody, A. R., Colby, T. V., Mason, R., & Williams, M. C. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200803-028hr · Cited by 187
‘WNT-er is coming’: WNT signalling in chronic lung diseases
Baarsma, H. A., & Königshoff, M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209753 · Cited by 185
Scar wars: mapping the fate of epithelial–mesenchymal–myofibroblast transition
Quaggin, S. E., & Kapus, A. (2011) · Kidney International · doi:10.1038/ki.2011.77 · Cited by 185
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Lawrence, J., & Nho, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030778 · Cited by 183
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0524oc · Cited by 181
Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices
Li, Y., & Kilian, K. A. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500427 · Cited by 179
Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis
Kang, Y. P., Lee, S. B., Lee, J.-M., Kim, H. M., Hong, J. Y., Lee, W. J., Choi, C. W., Shin, H. K., Kim, D.-J., Koh, E. S., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00156 · Cited by 179
Role of microRNAs in Lung Development and Pulmonary Diseases
Sessa, R., & Hata, A. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.114758 · Cited by 179
Choi, S.-H., Hong, Z.-Y., Nam, J.-K., Lee, H.-J., Jang, J., Yoo, R. J., Lee, Y. J., Lee, C. Y., Kim, K. H., Park, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3193 · Cited by 178
“In general, EMT is characterized by increased expression of α-SMA and vimentin, and decreased expression of the epithelial markers E-cadherin and pro-SP-c in alveolar epithelial type (AE) II cells (19).”
BackgroundSelf-citationNishimura, S. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090393 · Cited by 178
Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition
Balli, D., Ustiyan, V., Zhang, Y., Wang, I., Masino, A. J., Ren, X., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2013) · The EMBO Journal · doi:10.1038/emboj.2012.336 · Cited by 177
New Insights into the Regulation of Epithelial–Mesenchymal Transition and Tissue Fibrosis
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394305-7.00004-5 · Cited by 176
The WNT signaling pathways in wound healing and fibrosis
Burgy, O., & Königshoff, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.017 · Cited by 175
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis
Mehrad, B., Burdick, M. D., & Strieter, R. M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.020 · Cited by 175
TGF-beta signal transduction: biology, function and therapy for diseases
Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00109-9 · Cited by 174
Marmai, C., Sutherland, R. E., Kim, K. K., Dolganov, G. M., Fang, X., Kim, S. S., Jiang, S., Golden, J. A., Hoopes, C. W., Matthay, M. A., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00212.2010 · Cited by 172
Self-citationRequirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
Shan, B., Yao, T.-P., Nguyen, H. T., Zhuo, Y., Levy, D. R., Klingsberg, R. C., Tao, H., Palmer, M. L., Holder, K. N., & Lasky, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802786200 · Cited by 172
Lung cancer in patients with idiopathic pulmonary fibrosis
Karampitsakos, T., Tzilas, V., Tringidou, R., Steiropoulos, P., Aidinis, V., Papiris, S. A., Bouros, D., & Tzouvelekis, A. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.03.016 · Cited by 171
“yet it is premature to prove whether a linear association exists (12, 31, 52-55).”
BackgroundStem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., Rojas, M., Stripp, B., Warburton, D., & Prockop, D. J. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201012-071dw · Cited by 171
Apoptosis in lung injury and fibrosis
Drakopanagiotakis, F., Xifteri, A., Polychronopoulos, V., & Bouros, D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00176807 · Cited by 168
Barkauskas, C. E., & Noble, P. W. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00321.2013 · Cited by 167
Mechanical stress induces lung fibrosis by epithelial–mesenchymal transition*
Cabrera-Benítez, N. E., Parotto, M., Post, M., Han, B., Spieth, P. M., Cheng, W.-E., Valladares, F., Villar, J., Liu, M., Sato, M., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822f09d7 · Cited by 167
EMT and interstitial lung disease: a mysterious relationship
Kage, H., & Borok, Z. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283566721 · Cited by 165
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
Strippoli, R., Moreno-Vicente, R., Battistelli, C., Cicchini, C., Noce, V., Amicone, L., Marchetti, A., del Pozo, M. Á., & Tripodi, M. (2016) · Stem Cells International · doi:10.1155/2016/3543678 · Cited by 164
Wu, Z., Yang, L., Cai, L., Zhang, M., Cheng, X., Yang, X., & Xu, J. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-1 · Cited by 164
Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition
Gohy, S. T., Hupin, C., Fregimilicka, C., Detry, B. R., Bouzin, C., Gaide Chevronay, H., Lecocq, M., Weynand, B., Ladjemi, M. Z., Pierreux, C. E., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00135814 · Cited by 163
Velotti, F., Barchetta, I., Cimini, F. A., & Cavallo, M. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.587581 · Cited by 163
Progress Toward Improving Animal Models for Idiopathic Pulmonary Fibrosis
Degryse, A. L., & Lawson, W. E. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821aa000 · Cited by 162
Integrins and integrin-related proteins in cardiac fibrosis
Chen, C., Li, R., Ross, R. S., & Manso, A. M. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.11.010 · Cited by 162
“epithelial cell specific deletion of 3 integrin showed a reduction in myofibroblast number and collagen I deposition in the lungs, following bleomycin injury (a known inducer of fibrosis) compared to control treated mice [169].”
BackgroundZhang, Z., Qu, J., Zheng, C., Zhang, P., Zhou, W., Cui, W., Mo, X., Li, L., Xu, L., & Gao, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0198-x · Cited by 161
Epithelial plasticity, cancer stem cells and bone metastasis formation
van der Pluijm, G. (2010) · Bone · doi:10.1016/j.bone.2010.07.023 · Cited by 161
TLR9 Differentiates Rapidly from Slowly Progressing Forms of Idiopathic Pulmonary Fibrosis
Trujillo, G., Meneghin, A., Flaherty, K. R., Sholl, L. M., Myers, J. L., Kazerooni, E. A., Gross, B. H., Oak, S. R., Coelho, A. L., Evanoff, H., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001510 · Cited by 160
Integrin α3β1–dependent β-catenin phosphorylation links epithelial Smad signaling to cell contacts
Kim, Y., Kugler, M. C., Wei, Y., Kim, K. K., Li, X., Brumwell, A. N., & Chapman, H. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806067 · Cited by 160
Self-citationIL-6 ameliorates acute lung injury in influenza virus infection
Yang, M.-L., Wang, C.-T., Yang, S.-J., Leu, C.-H., Chen, S.-H., Wu, C.-L., & Shiau, A.-L. (2017) · Scientific Reports · doi:10.1038/srep43829 · Cited by 159
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
Epithelial–mesenchymal transition in the skin
Nakamura, M., & TOKURA, Y. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.11.015 · Cited by 158
Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice
Dong, Y., Geng, Y., Li, L., Li, X., Yan, X., Fang, Y., Li, X., Dong, S., Liu, X., Li, X., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20121878 · Cited by 157
Metadata
- Authors
- Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A.
- Affiliations
- University of California, San Francisco (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-29
- Volume
- 103
- Issue
- 35
- Pages
- 13180-13185
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2060126259
- Cited by
- 1,257
- References
- 27
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 51 · 2023: 60 · 2022: 57 · 2021: 62 · 2020: 64 · 2019: 63 · 2018: 73 · 2017: 89 · 2016: 72 · 2015: 68 · 2014: 63 · 2013: 74 · 2012: 92
- FWCI
- 43.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biogen
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R37HL053949, HL53949, R01HL044712, HL-04055, HL 44712, K08HL004055, R01HL053949)
- National Institute of General Medical Sciences (GM-075419, F32GM075419)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- alveolar epithelial cells, epithelial-mesenchymal transition, pulmonary fibrosis, fibroblast accumulation, fibrogenesis, TGF-β1, extracellular matrix, integrins, fibronectin, fibrin, laminin, collagen, vimentin, apoptosis
- MeSH terms
- Animals, beta-Galactosidase, Cells, Cultured, Collagen, Drug Combinations, Epithelial Cells, Extracellular Matrix, Fibronectins, Humans, Laminin, Mesoderm, Mice, Transgenic, Proteoglycans, Pulmonary Alveoli, Pulmonary Fibrosis, Transforming Growth Factor beta, Apoptosis, Genes, Reporter, Mice, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.